Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
31 hedge funds and large institutions have $7.03M invested in Nymox Pharmaceutical Corp in 2014 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 8 closing their positions.
70% more capital invested
Capital invested by funds: $4.14M → $7.03M (+$2.88M)
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
3% less funds holding
Funds holding: 32 → 31 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
64% less call options, than puts
Call options by funds: $439K | Put options by funds: $1.22M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Advisors Asset Management
Monument,
Colorado
|
+$1.35M |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
+$998K |
| 3 |
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
|
+$399K |
| 4 |
Millennium Management
New York
|
+$267K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$139K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$342K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$203K |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
-$109K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$88.8K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$52.7K |
NYMX Hedge Fund Activity: Q2 2014 in Review
31 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q2 2014, worth a combined $7.03M — up 70% from $4.14M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of NYMX and 7 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 7 added.
The largest buyer was Advisors Asset Management, adding an estimated $1.35M. The largest seller was Shepherd Kaplan Krochuk, exiting entirely with an estimated $342K sold.
- 31 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q2 2014, down from 32 in Q1 2014.
- Funds reported $7.03M of Nymox Pharmaceutical Corp stock for Q2 2014, up 70% quarter-over-quarter.
- 7 funds opened new Nymox Pharmaceutical Corp positions in Q2 2014 and 8 closed out, a net change of -1 holder.
- The largest Nymox Pharmaceutical Corp buyer in Q2 2014 was Advisors Asset Management, an estimated $1.35M added.
- The largest Nymox Pharmaceutical Corp seller in Q2 2014 was Shepherd Kaplan Krochuk, an estimated $342K sold.
Based on aggregated 13F filings for Q2 2014.